Search

everythinglearnresearchcommunity

for

Search:↓

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Understanding facial anatomy and early management are key to preventing and treating complications from injectable fillers.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Tannic acid helps wounds heal faster in rats by activating certain cell signals and reducing inflammation.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Deoxycholic acid is effective for reducing chin fat but can cause side effects and serious complications, so careful patient evaluation is needed.

Herbal products might promote hair growth with fewer side effects, but more research is needed to confirm their safety and effectiveness.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Alopecia areata involves immune response and gene changes affecting hair loss.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.